Clinical Trial Update: L-carnitine and Coenzyme Q10 in Relation to the Oxidative Stress, Antioxidant Enzymes Activities, Inflammation, and the Risk of Coronary Artery Disease [Phase 2, Phase 3]

View source ↗

Summary

This update notes completed Phase 2 and Phase 3 trials examining L-carnitine and Coenzyme Q10 for oxidative stress, inflammation, and antioxidant enzymes relate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Coenzyme Q10 (Coenzyme Q10)
• L-carnitine (L-carnitine)

Snippet

Sponsor: Taichung Veterans General Hospital | Conditions: Coronary Artery Disease | Phase 2, Phase 3 | Status: COMPLETED